IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-27190-y.html
   My bibliography  Save this article

CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease

Author

Listed:
  • Emmanouela Tsagkaraki

    (Program in Molecular Medicine, University of Massachusetts Medical School
    University of Crete School of Medicine)

  • Sarah M. Nicoloro

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Tiffany DeSouza

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Javier Solivan-Rivera

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Anand Desai

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Lawrence M. Lifshitz

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Yuefei Shen

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Mark Kelly

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Adilson Guilherme

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Felipe Henriques

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Nadia Amrani

    (University of Crete School of Medicine)

  • Raed Ibraheim

    (RNA Therapeutics Institute, University of Massachusetts Medical School)

  • Tomas C. Rodriguez

    (RNA Therapeutics Institute, University of Massachusetts Medical School)

  • Kevin Luk

    (Cell and Cancer Biology, University of Massachusetts Medical School)

  • Stacy Maitland

    (Cell and Cancer Biology, University of Massachusetts Medical School)

  • Randall H. Friedline

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Lauren Tauer

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Xiaodi Hu

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Jason K. Kim

    (Program in Molecular Medicine, University of Massachusetts Medical School
    University of Massachusetts Medical School)

  • Scot A. Wolfe

    (Cell and Cancer Biology, University of Massachusetts Medical School
    Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School)

  • Erik J. Sontheimer

    (Program in Molecular Medicine, University of Massachusetts Medical School
    RNA Therapeutics Institute, University of Massachusetts Medical School
    Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School)

  • Silvia Corvera

    (Program in Molecular Medicine, University of Massachusetts Medical School)

  • Michael P. Czech

    (Program in Molecular Medicine, University of Massachusetts Medical School)

Abstract

Obesity and type 2 diabetes are associated with disturbances in insulin-regulated glucose and lipid fluxes and severe comorbidities including cardiovascular disease and steatohepatitis. Whole body metabolism is regulated by lipid-storing white adipocytes as well as “brown” and “brite/beige” adipocytes that express thermogenic uncoupling protein 1 (UCP1) and secrete factors favorable to metabolic health. Implantation of brown fat into obese mice improves glucose tolerance, but translation to humans has been stymied by low abundance of primary human beige adipocytes. Here we apply methods to greatly expand human adipocyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermogenic suppressor gene NRIP1 by CRISPR. Ribonucleoprotein consisting of Cas9 and sgRNA delivered ex vivo are fully degraded by the human cells following high efficiency NRIP1 depletion without detectable off-target editing. Implantation of such CRISPR-enhanced human or mouse brown-like adipocytes into high fat diet fed mice decreases adiposity and liver triglycerides while enhancing glucose tolerance compared to implantation with unmodified adipocytes. These findings advance a therapeutic strategy to improve metabolic homeostasis through CRISPR-based genetic enhancement of human adipocytes without exposing the recipient to immunogenic Cas9 or delivery vectors.

Suggested Citation

  • Emmanouela Tsagkaraki & Sarah M. Nicoloro & Tiffany DeSouza & Javier Solivan-Rivera & Anand Desai & Lawrence M. Lifshitz & Yuefei Shen & Mark Kelly & Adilson Guilherme & Felipe Henriques & Nadia Amran, 2021. "CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27190-y
    DOI: 10.1038/s41467-021-27190-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-27190-y
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-021-27190-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Michael Roden & Gerald I. Shulman, 2019. "The integrative biology of type 2 diabetes," Nature, Nature, vol. 576(7785), pages 51-60, December.
    2. Amanda Finck & Saar I. Gill & Carl H. June, 2020. "Cancer immunotherapy comes of age and looks for maturity," Nature Communications, Nature, vol. 11(1), pages 1-4, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. M. Kyle Cromer & Valentin V. Barsan & Erich Jaeger & Mengchi Wang & Jessica P. Hampton & Feng Chen & Drew Kennedy & Jenny Xiao & Irina Khrebtukova & Ana Granat & Tiffany Truong & Matthew H. Porteus, 2022. "Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    2. Antoine Gagelin & Corentin Largeau & Sandrine Masscheleyn & Mathilde S. Piel & Daniel Calderón-Mora & Frédéric Bouillaud & Jérôme Hénin & Bruno Miroux, 2023. "Molecular determinants of inhibition of UCP1-mediated respiratory uncoupling," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zvonimir Bosnić & František Babič & Viera Anderková & Mario Štefanić & Thomas Wittlinger & Ljiljana Trtica Majnarić, 2023. "A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2," IJERPH, MDPI, vol. 20(4), pages 1-19, February.
    2. Dongliang Lu & Anyuan He & Min Tan & Marguerite Mrad & Amal El Daibani & Donghua Hu & Xuejing Liu & Brian Kleiboeker & Tao Che & Fong-Fu Hsu & Monika Bambouskova & Clay F. Semenkovich & Irfan J. Lodhi, 2024. "Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    3. Laura Y. Zhou & Fei Zou & Wei Sun, 2023. "Prioritizing candidate peptides for cancer vaccines through predicting peptide presentation by HLA‐I proteins," Biometrics, The International Biometric Society, vol. 79(3), pages 2664-2676, September.
    4. Shaza B. Zaghlool & Anna Halama & Nisha Stephan & Valborg Gudmundsdottir & Vilmundur Gudnason & Lori L. Jennings & Manonanthini Thangam & Emma Ahlqvist & Rayaz A. Malik & Omar M. E. Albagha & Abdul Ba, 2022. "Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    5. Zaid Taha & Mathieu Joseph François Crupi & Nouf Alluqmani & Duncan MacKenzie & Sydney Vallati & Jack Timothy Whelan & Faiha Fareez & Akram Alwithenani & Julia Petryk & Andrew Chen & Marcus Mathew Spi, 2024. "Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    6. M. Kyle Cromer & Valentin V. Barsan & Erich Jaeger & Mengchi Wang & Jessica P. Hampton & Feng Chen & Drew Kennedy & Jenny Xiao & Irina Khrebtukova & Ana Granat & Tiffany Truong & Matthew H. Porteus, 2022. "Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells," Nature Communications, Nature, vol. 13(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27190-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.